A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder

BACKGROUND: The N-methyl-d-aspartate glutamate receptor antagonist ketamine, delivered via an intravenous route, has shown rapid antidepressant effects in patients with treatment-resistant depression. The current study was designed to test the safety, tolerability and efficacy of intranasal ketamine...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lapidus, Kyle A.B., Levitch, Cara F., Perez, Andrew M., Brallier, Jess W., Parides, Michael K., Soleimani, Laili, Feder, Adriana, Iosifescu, Dan V., Charney, Dennis S., Murrough, James W.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185009/
https://ncbi.nlm.nih.gov/pubmed/24821196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopsych.2014.03.026
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados